GDP Non-Compliance Report: No Responsible Person, proper Storage and Distribution not ensured
Recommendation

8 September 2026
Basel, Switzerland
Specifics in the Distribution of Medicinal Products
The Competent Authority of Germany (Landesamt Fuer Gesundheit Und Soziales Mecklenburg Vorpommern) has entered a new GDP Non-Compliance Report into the EudraGMDP database.
In the report dated 16 April 2025, the authority writes that from the knowledge gained during an inspection on 15 April 2025, the following nature of GDP non-compliance was observed at a wholesale distributor located in Schwerin:
- "The wholesale distributor can not designate a responsible person.
- Furthermore, there are no suitable and adequate premises, installations and equipment, so as to ensure proper storage and distribution of medicinal products.
- The NCA was unable to carry out an inspection in accordance with § 64 of the Medicinal Products Act."
The wholesale authorisation was suspended. The suspension of the WDA is limited to two months. After this time, the WDA will be revoked.
Source: EudraGMDP Database (Inspection Date: 15 April 2025; Report Number: NC/410.0410/2025). *
* To find the respective report, please click on "Non-Compliance Reports" in the menu on the left-hand side and select in "From Date / To Date" the month the inspection took place. After clicking on "Search" the results list will be displayed, from which you can choose the report with the number mentioned above.
Related GMP News
14.07.2026USP Proposes to Revise the Definition of Controlled Room Temperature in Chapter <659>
14.07.2026GDP in Hong Kong: Authority Provides Additional Information
14.07.2026GDP Inspection Responses: MHRA’s Expectations for AI Use in GxP Replies
14.07.2026FDA Warning Letter to Amazon: Unapproved New Drugs Sold via Online Marketplace
18.06.2026GDPA Participated as an Observer in the EMA GMDP-IWG Interested Parties Meeting


